IN2013MU02532A - - Google Patents

Info

Publication number
IN2013MU02532A
IN2013MU02532A IN2532MU2013A IN2013MU02532A IN 2013MU02532 A IN2013MU02532 A IN 2013MU02532A IN 2532MU2013 A IN2532MU2013 A IN 2532MU2013A IN 2013MU02532 A IN2013MU02532 A IN 2013MU02532A
Authority
IN
India
Prior art keywords
medical device
mtor inhibitor
present disclosure
implantable medical
coated implantable
Prior art date
Application number
Other languages
English (en)
Inventor
Ankur Jaykumar Raval
Chhaya Babubhai Engineer
Vandana Bharat Patravale
Original Assignee
Sahajanand Medical Technologies Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahajanand Medical Technologies Pvt Ltd filed Critical Sahajanand Medical Technologies Pvt Ltd
Priority to IN2532MU2013 priority Critical patent/IN2013MU02532A/en
Priority to US14/908,251 priority patent/US10639403B2/en
Priority to ES14781268T priority patent/ES2744848T3/es
Priority to PL14781268T priority patent/PL3027236T3/pl
Priority to PCT/IB2014/001414 priority patent/WO2015015278A1/en
Priority to EP14781268.9A priority patent/EP3027236B1/en
Publication of IN2013MU02532A publication Critical patent/IN2013MU02532A/en
Priority to HK16110221.2A priority patent/HK1221918A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/143—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/02—Methods for coating medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
IN2532MU2013 2013-07-31 2013-07-31 IN2013MU02532A (pl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN2532MU2013 IN2013MU02532A (pl) 2013-07-31 2013-07-31
US14/908,251 US10639403B2 (en) 2013-07-31 2014-07-30 mTOR inhibitor eluting medical device
ES14781268T ES2744848T3 (es) 2013-07-31 2014-07-30 Dispositivo médico de liberación de inhibidor de mTOR
PL14781268T PL3027236T3 (pl) 2013-07-31 2014-07-30 Urządzenie medyczne uwalniające inhibitor mTOR
PCT/IB2014/001414 WO2015015278A1 (en) 2013-07-31 2014-07-30 mTOR INHIBITOR ELUTING MEDICAL DEVICE
EP14781268.9A EP3027236B1 (en) 2013-07-31 2014-07-30 Mtor inhibitor eluting medical device
HK16110221.2A HK1221918A1 (zh) 2013-07-31 2016-08-29 洗脫 抑制劑的醫療裝置

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2532MU2013 IN2013MU02532A (pl) 2013-07-31 2013-07-31

Publications (1)

Publication Number Publication Date
IN2013MU02532A true IN2013MU02532A (pl) 2015-06-26

Family

ID=51662153

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2532MU2013 IN2013MU02532A (pl) 2013-07-31 2013-07-31

Country Status (7)

Country Link
US (1) US10639403B2 (pl)
EP (1) EP3027236B1 (pl)
ES (1) ES2744848T3 (pl)
HK (1) HK1221918A1 (pl)
IN (1) IN2013MU02532A (pl)
PL (1) PL3027236T3 (pl)
WO (1) WO2015015278A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201505527D0 (en) * 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
CA3078555A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
CN114146231A (zh) * 2020-09-07 2022-03-08 上海鸿脉医疗科技有限公司 药物球囊及其制备方法
CN115300675A (zh) * 2022-03-21 2022-11-08 上海以心医疗器械有限公司 一种药物涂层医疗器械及其制备方法与应用、药物涂层及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
GB9826882D0 (en) 1998-12-07 1999-01-27 Novartis Ag Organic compounds
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US20090324682A1 (en) * 2004-08-30 2009-12-31 Youri Popowski Medical stent provided with inhibitors of atp synthesis
US20080077232A1 (en) 2004-09-08 2008-03-27 Kaneka Corporation Stent for Placement in Body
EP1832289A3 (en) * 2006-03-08 2007-12-12 Sahajanand Medical Technologies PVT. ltd Compositions and coatings for implantable medical devices
US20080004695A1 (en) 2006-06-28 2008-01-03 Abbott Cardiovascular Systems Inc. Everolimus/pimecrolimus-eluting implantable medical devices
EP2101683A4 (en) 2007-01-11 2014-12-03 Robert Lamar Bjork Jr KORONARARTERIENSTENT FOR THE RELEASE OF SEVERAL MEDICAMENTS AND FOR PERCUTANEOUS CORONARTERIES
US8420110B2 (en) * 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
WO2009150650A2 (en) 2008-06-12 2009-12-17 Ramot At Tel Aviv University Ltd. Drug-eluting medical devices
WO2013102842A2 (en) 2012-01-06 2013-07-11 Sahajanand Medical Technologies Private Limited Device and composition for drug release

Also Published As

Publication number Publication date
HK1221918A1 (zh) 2017-06-16
ES2744848T3 (es) 2020-02-26
EP3027236A1 (en) 2016-06-08
US20160151545A1 (en) 2016-06-02
PL3027236T3 (pl) 2019-12-31
WO2015015278A1 (en) 2015-02-05
US10639403B2 (en) 2020-05-05
EP3027236B1 (en) 2019-05-22

Similar Documents

Publication Publication Date Title
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
EP3054953A4 (en) Hdac inhibitors, alone or in combination with pi3k inhibitors, for treating non-hodgkin's lymphoma
MX344599B (es) Sistemas y metodos para utilizar terapia para heridas con presion negativa para manejar heridas abdominales abiertas.
CL2013002934A1 (es) Polimeros conjugados analogos de prostaglandinas; metodo de preparacion; implante y uso en el tratamiento del glaucoma.
MX2015011806A (es) Aposito antimicrobiano multifuncional para la cobertura de un cateter.
WO2014040074A3 (en) Compositions and methods for treating cutaneous scarring
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MY163031A (en) Method of treating obesity using antioxidant inflammation modulators
EP3081597A4 (en) Fluorine-containing ether composition, method for producing same, coating liquid, base material having surface treatment layer, and method for producing same
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
MX352192B (es) Formas de dosificación sólidas que comprenden miel en el recubrimiento.
MX365242B (es) El uso del antagonista cxcr4: 1,1´-[1,4-fenileno-bis-(metileno)-bi s-1, 4, 8, 11-tetraazaciclotetradecano (plerixaflor) para el tratamiento del síndrome de whim.
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
RS53467B (en) USE OF AMISULPRID FOR TREATMENT OF Nausea and Vomiting Caused by Chemotherapy
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
BR112015017427A2 (pt) artigo compreendendo um substrato polimérico e uma camada de polímero de silicone
WO2014106825A3 (en) Methods and devices for identifying improper medical reporting
IN2013MU02532A (pl)
GB2541854A (en) Patterned surfaces
GB201201753D0 (en) Therapeutic agents with improved fibrinogen binding
WO2015156674A3 (en) Method for treating cancer
MY184693A (en) Bilayer hydrocolloid films containing therapeutic agents
EP2568990A4 (en) METHOD OF PRODUCING PLEURODESIS
WO2013102842A3 (en) Device and composition for drug release
MD20160040A2 (ro) Pidotimod pentru utilizare în tratamentul bolilor asociate cu inflamaţie